9 Meters Biopharma, Inc. Gains 31.11%

9 Meters Biopharma, Inc. (NMTR:NASDAQ) shot up at $0.35, a gain of 31.1%. The stock got featured on our News Catalysts scanner on Tue, Jun 21, 2022 at 09:49 AM in the 'BIOTECH' category. From Thu, Jun 09, 2022, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Thu, Jun 09, 2022 at $0.66 with a volume of 2M+.
About 9 Meters Biopharma, Inc. (NMTR:NASDAQ)
Innovate Biopharmaceuticals Inc is a clinical stage biotechnology company. The company is engaged in developing novel medicines for an autoimmune/ inflammatory disease. It includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis.
Top 10 Gainers:
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 263.03%
- RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
- F-star Therapeutics Inc. (FSTX:NASDAQ), 59.8%
- TDH Holdings, Inc. (PETZ:NASDAQ), 54.74%
- Vroom Inc. (VRM:NASDAQ), 36.44%
- Rain Therapeutics Inc. (RAIN:NASDAQ), 32.82%
- Molecular Data Inc. (MKD:NASDAQ), 32.18%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 31.61%
- 22nd Century Group Inc (XXII:NASDAQ), 31.12%
- 9 Meters Biopharma, Inc. (NMTR:NASDAQ), 31.11%